Antibody delivery technology empowers immunotherapy against glioblastoma and suppresses side effects
Summary: •An antibody delivery technology was developed based on multiple glucosylated polymers conjugated onto antibodies via linkers cleaving in tumor microenvironment. •The delivery technology enhanced...